The abstract is read at the publisher; the summary is JClub's.
Five-year outcomes after a de-escalated 30-Gy elective nodal irradiation regimen during definitive concurrent chemoradiotherapy are reported for patients with HPV-associated oropharyngeal carcinoma.
- Why it matters: De-escalation aims to reduce treatment intensity while maintaining durable control in HPV-associated oropharyngeal cancer, where long-term outcomes are critical for weighing benefits and risks.
- What they did: In a cohort study, investigators followed patients receiving a 30-Gy elective nodal irradiation schedule as part of definitive concurrent chemoradiotherapy and assessed outcomes over 5 years.
- The result: The study provides 5-year outcome data for this specific de-escalated 30-Gy regimen, informing how such elective nodal de-intensification performs long term in HPV-associated oropharyngeal carcinoma.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.